What's hot, what's not, in dementia drugs. Part II
Research is dramatically increasing our understanding of what goes awry in the brains of persons with AD. Three compounds approved for use in other conditions, estrogen, anti-inflammatory drugs, and antioxidants, are currently under study based on their ability to promote cell metabolism and survival, counteract inflammatory responses, and protect neurons from oxidative damage. All three show promise in terms of treating and possibly preventing Alzheimer's disease.
Kathleen Buckwalter. "What's hot, what's not, in dementia drugs. Part II" Journal of gerontological nursing 23.12 (1997): 46-47.
Available at: http://works.bepress.com/kathleen_buckwalter/168
This document is currently not available here.